Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801451200 on May 8, 2008

J. Biol. Chem., Vol. 283, Issue 27, 18621-18626, July 4, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/27/18621    most recent
M801451200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, M.
Right arrow Articles by Sun, S.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, M.
Right arrow Articles by Sun, S.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of I{kappa}B Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD*Formula

Minying Zhang{ddagger}1, Xuefeng Wu{ddagger}1, Andrew J. Lee{ddagger}§, Wei Jin{ddagger}, Mikyoung Chang{ddagger}, Ato Wright{ddagger}§, Tadaatsu Imaizumi, and Shao-Cong Sun{ddagger}2

From the {ddagger}Department of Immunology, the University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, the §Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, and the Department of Vascular Biology, Hirosaki University School of Medicine, Hirosaki 036-8562, Japan

The I{kappa}B kinase (IKK)-related kinases, IKK{epsilon} and TBK1, participate in the induction of type I interferons (IFNs) during viral infections. Deregulated activation of IKK{epsilon} and TBK1 also contributes to the abnormal cell survival and transformation. However, how these kinases are negatively regulated remains unclear. We show here that the tumor suppressor CYLD has an essential role in preventing aberrant activation of IKK{epsilon}/TBK1. CYLD deficiency causes constitutive activation of IKK{epsilon}/TBK1, which is associated with hyper-induction of IFNs in virus-infected cells. We further show that CYLD targets a cytoplasmic RNA sensor, RIG-I, and inhibits the ubiquitination of this IKK{epsilon}/TBK1 stimulator. Consistent with the requirement of ubiquitination in RIG-I function, CYLD potently inhibits RIG-I-mediated activation of the IFN-β promoter. These findings establish CYLD as a key negative regulator of IKK{epsilon}/TBK1 and suggest a role for CYLD in the control of RIG-I ubiquitination.


Received for publication, February 22, 2008 , and in revised form, May 8, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grants AI064639, AI057555, and CA94922. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.

1 Both authors contributed equally to this work.

2 To whom correspondence should be addressed. Tel.: 713-563-3218; Fax: 713-563-3280; E-mail: ssun{at}mdanderson.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. C. Srokowski, J. Masri, N. Hovelmeyer, A. K. Krembel, C. Tertilt, D. Strand, K. Mahnke, R. Massoumi, A. Waisman, and H. Schild
Naturally occurring short splice variant of CYLD positively regulates dendritic cell function
Blood, June 4, 2009; 113(23): 5891 - 5895.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
T. H. Mogensen
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Clin. Microbiol. Rev., April 1, 2009; 22(2): 240 - 273.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Sanada, G. Takaesu, R. Mashima, R. Yoshida, T. Kobayashi, and A. Yoshimura
FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway
J. Biol. Chem., December 5, 2008; 283(49): 33858 - 33864.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement